MedPath

Cognitive adverse effects of anti-epileptic drugs investigated using fMRI

Withdrawn
Conditions
convulsions
epilepsy
10039911
Registration Number
NL-OMON35526
Lead Sponsor
Epilepsiecentrum Kempenhaeghe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Age over 18 years old, able to give informed consent, using anti-epileptic drugs when investigations take place.

Exclusion Criteria

Absolute or relative contra-indications for MR scanning, unable to peform tasks in MR or unable to complete the questionnaires.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters/endpoints: Network describing MR parameters, especially<br /><br>fMRI and functional connectivity; Relations between these parameters and<br /><br>changes in anti-epileptic drugs used.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The MR parameters and anti-epileptic drug use will be correlated with<br /><br>neuropsychological test results.</p><br>
© Copyright 2025. All Rights Reserved by MedPath